Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.80 |
| ▸ | ESR1 | P03372 | 6/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.80 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.80 |
| ▸ | ATM | Q13315 | 3/20 | 0.80 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.80 |
| ▸ | SHBG | P04278 | 1/20 | 0.80 |
| ▸ | FYN | P06241 | 1/20 | 0.80 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.80 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.80 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.80 |
| ▸ | HTR2B | P41595 | 1/20 | 0.80 |
| ▸ | HTT | P42858 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 6/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | TP53 | P04637 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | STS | P08842 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3299315 | 0.95 | MAPT (0.81) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL8155723 | 0.95 | MAPT (0.81) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL8722555 | 0.93 | KMT2A (0.69) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL3864661 | 0.92 | KMT2A (0.68) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL3870740 | 0.92 | KMT2A (0.68) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| Iodide SCHEMBL8723547 | 0.91 | KMT2A (0.67) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| Iodide SCHEMBL8723544 | 0.91 | KMT2A (0.67) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL2596563 | 0.91 | LMNA (0.71) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL19393251 | 0.90 | KMT2A (0.70) | LMNAKMT2AESR1SMN1; SMN2ADORA3 | |
| SCHEMBL8722468 | 0.90 | MAPT (0.65) | LMNAKMT2AESR1SMN1; SMN2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2073856-B1 | COATED IMPLANT | ARTIC GMBH (DE) | 2014-03-05 | — | — | EP | disclosed |
| US-20100158974-A1 | COATED IMPLANT | SCHOEMIG ALBERT | 2010-06-24 | — | — | US | disclosed |
| US-20100094410-A1 | COATED IMPLANT | SCHOEMIG ALBERT | 2010-04-15 | — | — | US | disclosed |
| US-20090177280-A1 | Implant With Multiple Coating | SCHOEMIG ALBERT | 2009-07-09 | — | — | US | disclosed |
| EP-1933893-A1 | IMPLANT WITH MULTIPLE COATING | Schömig, Albert (DE) | 2008-06-25 | — | — | EP | disclosed |
| EP-1916006-A1 | Implant coated with a wax or a resin | Schömig, Albert (DE) | 2008-04-30 | — | — | EP | disclosed |
| EP-1913960-A1 | Coated implant | Schömig, Albert (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1776970-A1 | Implant with multiple coating | Schömig, Albert (DE) | 2007-04-25 | — | — | EP | disclosed |
| WO-2007042294-A1 | IMPLANT WITH MULTIPLE COATING | SCHOEMIG ALBERT (DE) | 2007-04-19 | — | — | WO | disclosed |
| US-4009266-A | METHOD OF TREATMENT OF NEMATODE PARASITE INFECTIONS IN DOMESTIC ANIMALS | AYALEW LIYEW | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158974-A1 | COATED IMPLANT | CROCC, TET3, STUB1 | LMNA 3724/4885KMT2A 266/4885ESR1 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.